Z-0412-2020 Class II Terminated

Recalled by Randox Laboratories, Limited — Crumlin, N/A

FDA device recall Z-0412-2020 was initiated by Randox Laboratories, Limited on Oct 4, 2019 and is designated Class II. Reason for recall: Removal of claims for N-proBNP in the Liquid Cardiac Control model numbers CQ5051 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots. The recall status is terminated (terminated Jul 6, 2020). Affected quantity: 6,208.

Recall details

Product Type
Devices
Report Date
Nov 27, 2019
Initiation Date
Oct 4, 2019
Termination Date
Jul 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,208

Product description

Randox Liquid Cardiac Controls Catalogue Number CQ5051

Reason for recall

Removal of claims for N-proBNP in the Liquid Cardiac Control model numbers CQ5051 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.

Distribution pattern

US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,

Code information

Catalogue Number: CQ5051 GTIN: 05055273207446 Batch/lot: 4243CK (Exp. 28Nov2019), 4246CK (Exp. 28Nov2019), 4249CK (Exp. 28Nov2019), 4260CK (Exp. 28Nov2019), 4311CK (Exp. 28May2020), 4317CK (Exp. 28May2020)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0412-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0412-2020. Report a data issue: hello@regdatalab.com.